Bayer AG
BAYRY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $11,288 | $10,739 | $13,738 | $11,729 |
| % Growth | 5.1% | -21.8% | 17.1% | – |
| Cost of Goods Sold | $4,307 | $4,364 | $5,625 | $5,723 |
| Gross Profit | $6,255 | $6,375 | $8,113 | $6,006 |
| % Margin | 55.4% | 59.4% | 59.1% | 51.2% |
| R&D Expenses | $1,750 | $1,408 | $1,458 | $1,725 |
| G&A Expenses | $482 | $513 | $548 | $736 |
| SG&A Expenses | $3,405 | $3,545 | $3,707 | $4,335 |
| Sales & Mktg Exp. | $2,923 | $3,032 | $3,159 | $3,599 |
| Other Operating Expenses | $741 | $1,409 | $624 | -$3,586 |
| Operating Expenses | $5,896 | $6,362 | $5,789 | $2,474 |
| Operating Income | $656 | $13 | $2,324 | $3,532 |
| % Margin | 5.8% | 0.1% | 16.9% | 30.1% |
| Other Income/Exp. Net | -$2,012 | -$439 | -$494 | -$4,013 |
| Pre-Tax Income | -$1,357 | -$426 | $1,830 | -$481 |
| Tax Expense | -$236 | -$236 | $526 | -$153 |
| Net Income | -$1,125 | -$199 | $1,299 | -$335 |
| % Margin | -10% | -1.9% | 9.5% | -2.9% |
| EPS | -0.29 | -0.05 | 0.33 | -0.085 |
| % Growth | -480% | -115.2% | 488.2% | – |
| EPS Diluted | -0.29 | -0.05 | 0.33 | -0.085 |
| Weighted Avg Shares Out | 3,930 | 3,930 | 3,930 | 3,930 |
| Weighted Avg Shares Out Dil | 3,930 | 3,930 | 3,930 | 3,930 |
| Supplemental Information | – | – | – | – |
| Interest Income | $152 | $92 | $92 | $114 |
| Interest Expense | $890 | $561 | $584 | $385 |
| Depreciation & Amortization | $1,005 | $272 | $1,174 | $1,767 |
| EBITDA | $606 | $236 | $3,588 | $1,671 |
| % Margin | 5.4% | 2.2% | 26.1% | 14.2% |